Goodwin-Led BridgeBio Tops 3 Biotech IPOs Totaling $749M
BridgeBio Pharma priced shares in a $348.5 million initial public offering steered by Goodwin Procter LLP, leading the way as three biotechnology firms hit the market Thursday after raising a combined...To view the full article, register now.
Already a subscriber? Click here to view full article